TY - JOUR
T1 - Interventional cytopathology and cancer in peru
T2 - How to act during covid-19?
AU - Abad-Licham, Milagros
AU - Astigueta, Juan
AU - Fernández, Caddie Laberiano
AU - Torres, Himelda Chávez
AU - Torres, Grisnery Maquera
AU - Figueroa, Edwin
AU - Bardales, Ricardo
N1 - Publisher Copyright:
© 2020 ecancer Global Foundation. All rights reserved.
PY - 2021
Y1 - 2021
N2 - The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.
AB - The worldwide health crisis due to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected all healthcare systems. Low- and middle-income countries have needed to establish health strategies to combat the pandemic, many of which have collaterally affected the diagnosis and treatment of other illnesses. One of these other illnesses is cancer, which in Peru represents the primary cause of mortality. In recent decades, interventional cytopathology with fine-needle biopsy techniques has emerged as a minimally invasive, rapid, economical and effective procedure for diagnosing and staging cancer. However, in the current health context, it is confronted by the challenge of continuing to function in spite of the pandemic. This article reviews the existing literature on interventional cytopathology, the risk of infection from SARS-CoV-2 and biosafety and provides recommendations for carrying out said procedures for the benefit of the patient and the safety of healthcare staff.
KW - Biosafety
KW - Cancer
KW - COVID-19
KW - Fine-needle biopsy
UR - http://www.scopus.com/inward/record.url?scp=85098738596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098738596&partnerID=8YFLogxK
U2 - 10.3332/ECANCER.2020.1152
DO - 10.3332/ECANCER.2020.1152
M3 - Article
C2 - 33574897
AN - SCOPUS:85098738596
SN - 1754-6605
VL - 14
JO - ecancermedicalscience
JF - ecancermedicalscience
M1 - 1152
ER -